CIA
RMD icon

Concurrent Investment Advisors’s ResMed RMD Stock Holding History

Concurrent Investment Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
5,002
+1,950
+64% +$486K 0.01% 830
2025
Q4 		$735K Buy
3,052
+746
+32% +$191K 0.01% 969
2025
Q3 		$631K Buy
2,306
+80
+4% +$21.9K 0.01% 817
2025
Q2 		$574K Buy
2,226
+59
+3% +$14.1K 0.01% 798
2025
Q1 		$485K Buy
2,167
+356
+20% +$83.1K 0.01% 761
2024
Q4 		$414K Sell
1,811
-108
-6% -$26K 0.01% 727
2024
Q3 		$469K Buy
1,919
+57
+3% +$12.7K 0.01% 640
2024
Q2 		$356K Buy
1,862
+678
+57% +$138K 0.01% 683
2024
Q1 		$234K Buy
+1,184
New +$217K 0.01% 747

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Concurrent Investment Advisors's RMD Position: Q1 2026 in Review

Concurrent Investment Advisors increased its ResMed (RMD) stake by 64% in Q1 2026, buying an estimated $486K and bringing the position to 5,002 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #830.

Concurrent Investment Advisors first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Concurrent Investment Advisors held 5,002 shares of ResMed worth $1.12M as of Q1 2026.
  • Concurrent Investment Advisors bought 1,950 ResMed shares in Q1 2026, an estimated $486K.
  • ResMed made up 0.01% of Concurrent Investment Advisors's portfolio in Q1 2026, its #830 holding.
  • Concurrent Investment Advisors first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Concurrent Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.